根据新的IASLC/ATS/ERS进行的基于模式的分级系统在I期肺腺癌亚洲患者中的预后影响

Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma
2016-01-05 10:55点击:354次发表评论
作者:Zhao, Z.-R., Xi, S.-Y., Li, W., Situ, D.-R., Chen, K.-M., Yang, H., Su, X.-D., Lin, Y.-B., Long, H.
机构: 中山大学肿瘤中心 胸外科 肿瘤医学协同创新中心 华南肿瘤国家重点实验室
期刊: LUNG CANCER2015年12月3期90卷

Objectives: We examined the prognostic effect of the grading system based on the new IASLC/ATS/ERS classification in an Asian cohort of patients with early-stage lung adenocarcinoma. Materials and methods: Patients with a lung adenocarcinoma less than 3cm in diameter that had undergone complete anatomic resection, diagnosed with pT1a-2aN0M0 consecutively from 2004 to 2013, were enrolled. All specimens were reviewed according to the new IASLC/ATS/ERS classification. The growth patterns were divided into three major categories: grade 1 for lepidic growth, grade 2 for acinar and papillary patterns, and grade 3 for solid and micropapillary patterns. Each tumor was then graded according to the modified grading system, the final score being the sum of the two most predominant grades. The correlations of clinical and pathological factors with disease-free survival (DFS) and overall survival (OS) were evaluated. Results: In total, 201 adenocarcinomas were eligible for score grading. Only 37 (18.4%) patients had a pure pathological growth pattern. Higher stage, greater tumor diameter, positive lymphovascular invasion, and a higher score were associated with shorter DFS. In contrast, stage no longer had a significant impact on OS in a multivariable analysis. Acinar/papillary-predominant tumors with a score of 3 or 4 were associated with better survival than those with a score of 5 (5-year DFS rate: 64.68 vs. 44.18%, HR=2.19, 95% CI: 1.24-3.87; 5-year OS rate: 85.61 vs. 68.59%, HR=3.03, 95% CI: 1.25-7.32). Conclusion: The architectural scores may help to stratify survival differences among certain predominant growth subtypes of adenocarcinoma. © 2015 Elsevier Ireland Ltd.

 

通讯机构:State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine and Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
学科代码:呼吸病学 肿瘤学   关键词:IASLC/ATS/ERS I期肺腺癌 亚洲患者 ,中国作者重要发表 爱思唯尔医学网, Elseviermed
来源: Scopus
Scopus介绍:Scopus 于2004年11月正式推出,是目前全球规模最大的文摘和引文数据库。Scopus涵盖了由5000多家出版商出版发行的科技、医学和社会科学方面的18,000多种期刊,其中同行评审期刊16,500多种。相对于其他单一的文摘索引数据库而言,Scopus的内容更加全面,学科更加广泛,特别是在获取欧洲及亚太地区的文献方面,用户可检索出更多的文献数量。通过Scopus,用户可以检索到1823年以来的近4000万条摘要和题录信息,以及1996年以来所引用的参考文献。数据每日更新。 马上访问Scopus网站http://www.scopus.com/
顶一下(0
您可能感兴趣的文章
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录